Introduction
============

Neurogenesis is defined as the generation of new functional neurons, including the proliferation of neural stem/progenitor cells (NSCs), differentiation of these cells into new neurons, and maturation of new neurons that integrate into the neural circuitry. Currently, mammalian neurogenesis is divided into two phases: embryonic/developmental neurogenesis which forms the central nervous system (CNS) and adult neurogenesis which continues at low levels in postnatal and adult brains (Ming and Song, [@B115]). NSCs are the cellular basis of embryonic and adult neurogenesis and these cells share many regulatory factors and pathways. However, they have inherent differences and reside in distinct environments (Li and Zhao, [@B95]).

Epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs) have emerged as key regulators of gene expression that are required for NSC maintenance and fate specification. Recent literature has shown that maintaining the stemness of NSCs requires the epigenetic suppression of neuronal and glial genes, whereas NSC differentiation requires the removal of epigenetic suppression of genes necessary for neuronal or glial fate specification. In addition, many extrinsic signals, both under normal conditions and during disease and injury, can modulate this process (Hsieh and Eisch, [@B67]). In this review, we discuss the contribution of epigenetic mechanisms to NSC regulatory networks, with a particular emphasis on adult neurogenesis, and how epigenetic regulation mediates the environmental impact on neurogenesis. Understanding the regulatory mechanisms that govern NSCs, particularly when it comes to adult neurogenesis, is critical for regenerative medicine.

Neurogenesis
============

Neural stem cells are multipotent cells characterized by their abilities to self-renew and to generate differentiated cells in the nervous system. During development, radial glia in the neuroepithelium are the NSCs that generate the entire CNS. These radial glia produce cortical neurons either directly or indirectly through intermediate progenitor cells (Malatesta et al., [@B108]; Heins et al., [@B65]). At the end of neurogenesis, the neurogenic radial glia become translocating cells that are astrocytes (Kriegstein and Alvarez-Buylla, [@B85]). The three major cell types in the CNS arise from NSCs in a temporally defined sequence: neurons appear first, followed by astrocytes, and then oligodendrocytes (Kriegstein and Alvarez-Buylla, [@B85]).

In adult brains, neurogenesis has largely stopped, but multipotent NSCs have been found to exist in many brain regions. There are two areas of the adult CNS confirmed to have ongoing neurogenesis, a process defined by the production of new neurons. These neurogenic regions include the subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus and the subventricular zone (SVZ) bordering the lateral ventricles (Li and Zhao, [@B95]). In these regions, radial glia-like stem cells (RGLs) give rise to intermediate or transit-amplifying progenitors that subsequently differentiate into immature and then mature neurons. Experimental evidence suggests that adult NSCs originate from the embryonic neuroepithelial cells, mostly radial glia, located in the ventricular zone (Li and Zhao, [@B95]).

The specific purpose of adult neurogenesis is not entirely clear; although still debated, mounting evidence points to important roles for it in adult learning and memory (Aimone et al., [@B2]; Ming and Song, [@B115]). For instance, ablating adult neuroprogenitors via mouse genetics, anti-proliferative drugs, or focal irradiation impairs hippocampus-dependent learning (Shors et al., [@B159]; Barkho et al., [@B12], [@B11]; Saxe et al., [@B149]; Winocur et al., [@B188]; Dupret et al., [@B43]; Farioli-Vecchioli et al., [@B48]; Imayoshi et al., [@B70]; Clelland et al., [@B31]; Deng et al., [@B41]; Garthe et al., [@B54]; Jessberger et al., [@B71]); conversely, treatments that enhance neurogenesis also enhance hippocampus-dependent learning (Kitamura et al., [@B80]; Creer et al., [@B34]; Stone et al., [@B170]). Our recent publications, in which we enhanced or inhibited neurogenesis via mouse genetics, demonstrate a direct link between adult neurogenesis and hippocampus-dependent learning (Guo et al., [@B59], [@B61]). Moreover, both adult neurogenesis and learning are altered in several pathological conditions (Kempermann et al., [@B77]; Deng et al., [@B40]). As expected, the quiescence of RGLs, the cell-cycle progression and differentiation of IPCs, and the maturation of new neurons are all tightly controlled by intricate molecular networks that consist of intrinsic genetic and epigenetic programs modulated by extrinsic physiological and pathological conditions (Barkho et al., [@B12]; Smrt and Zhao, [@B167]; Barkho and Zhao, [@B13]). Therefore, adult NSCs (aNSCs) may play major roles in both normal brain functions, such as learning and memory, as well as the brain's response to injury and disease.

Neural stem cells isolated from the rodent adult SVZ, DG, or forebrain can be maintained as multipotent progenitor cells in serum-free media with defined supplemental factors and the presence of the mitogens basic fibroblast growth factor (bFGF or FGF2) and epithelial growth factor (EGF). Clonal analyses have shown that these NSCs can be instructed to differentiate into all three major cell lineages of the brain (neurons, astrocytes, and oligodendrocytes). Therefore, the *in vitro* culture of NSCs makes not only a good system for studying neurogenesis, but also an excellent source of cells for potential cell-based therapies (Barkho et al., [@B11]; Barkho and Zhao, [@B13]). Understanding aNSCs and adult neurogenesis holds the key to therapeutic applications for not just aNSCs, but many other types of stem cells, as well. In addition, aNSCs make an excellent model system for studying neurodevelopment and related disorders that have a postnatal etiology, such as autism spectrum disorders. Extensive efforts have been invested in this goal. In this review, we will focus on how epigenetic mechanisms, and particularly how crosstalk among epigenetic mechanisms, regulate neurogenesis.

Epigenetic Mechanisms
=====================

The term "epigenetics" was crafted by Conrad H. Waddington in 1942, before the age of DNA, to indicate the "study of those processes by which genotype gives rise to phenotype." Over the years, the meaning of "Epigenetics" has gone through a number of modifications as our knowledge of gene regulation grows. At present, "Epigenetics" is defined as "changes in the expression or function of genetic elements that are independent of changes to the DNA sequence." This loose, modern definition includes three general mechanisms: histone modifications, DNA methylation and related modifications, and ncRNAs. This definition encompasses how a single fertilized egg can give rise to a vast array of cell types through the transmission of epigenetic programs to daughter cells (Hsieh and Eisch, [@B67]; Smrt and Zhao, [@B167]). Recent work has revealed that epigenetic mechanisms can also integrate external stimuli into regulation of the neurogenic process (Molfese, [@B117]). Epigenetic mechanisms are increasingly recognized as dynamic regulators of gene expression, especially in the field of neurogenesis. The distinct boundaries between epigenetic pathways are blurring as more interactions are uncovered. This crosstalk is increasingly recognized as an important component of NSC regulation.

DNA methylation
---------------

DNA methylation is well known for its role in long-term gene silencing; it serves as the basis of imprinting, X chromosome inactivation, and the establishment of cell fate (Klose and Bird, [@B82]; Edwards and Ferguson-Smith, [@B45]; Reik, [@B140]). DNA methylation involves the covalent addition of a methyl group from the cofactor *S*-adenosyl-[l]{.smallcaps}-methionine (SAM) to C5 of cytosine in CpG dinucleotides and is catalyzed by a family of DNA methyltransferases (DNMTs). DNMT3a and DNMT3b establish *de novo* methylation, whereas DNMT1 maintains methylation patterns in daughter cells by recognizing hemi-methylated DNA and methylating the unmodified strand of newly synthesized DNA (Law and Jacobsen, [@B89]). DNA methylation is essential during development, as DNMT null mutations are embryonic lethal (Bestor, [@B16]). During the neural induction of embryonic stem cells (ESCs) to NSCs, many pluripotency genes are methylated and silenced, which shows the importance of DNA methylation during neurogenesis (Mohn et al., [@B116]). Interestingly, patterns of DNA methylation correlate more strongly with histone modification patterns than with the underlying genetic code, highlighting the interplay between these two systems (Meissner et al., [@B112]).

The role of dynamic DNA methylation in cell lineage specification is still murky. Until recently, methylation was thought to be a static DNA modification, with demethylation occurring only passively upon the reduction of DNMT levels, but a number of reports have suggested dynamic DNA methylation changes that involve active demethylation (Ooi et al., [@B127]; Chen and Riggs, [@B27]). The most convincing data include the neuronal activity-dependent demethylation mediated by a DNA excision repair protein, Gadd45b (Ma et al., [@B104]); however the existence and biological functions of active demethylation remain controversial. Hydroxymethylated cytosine (5hmC), which is particularly abundant in brain tissue and ESCs, is a critical intermediate in the demethylation pathway. Proteins from three families catalyze active DNA demethylation: ten-eleven translocation (TET) family proteins modify methylated cytosines by hydroxylation, and then by further oxidation to produce 5mC or 5hmC; enzymes of the AID/APOBEC family deaminate the base of 5mC or 5hmC; and finally, members of the UDG family of base excision repair (BER) glycosylases remove 5hmC via DNA repair mechanisms (Bhutani et al., [@B18]). 5hmC is hypothesized to play a role in maintaining the pluripotency of ESCs (Cimmino et al., [@B30]) and in activity-dependent gene expression regulation in the brain (Guo et al., [@B58]); however, how 5hmC and DNA demethylation regulate neurogenesis remains a question.

Although DNA methylation may block gene repression by directly preventing the binding of certain transcription factors, DNA methylation-induced gene repression is primarily mediated by methyl-CpG-binding proteins (MBPs), which can recognize and bind to methylated DNA, and the recruitment of chromatin remodeling complexes (Defossez and Stancheva, [@B39]). The MBP family is divided into three branches: proteins containing methyl binding domain (MBD), including MBD1--5 and MeCP2; members of the Kaiso family of methyl-CpG binding zinc fingers; and UHRF1 and 2 proteins containing the SET and RING finger-associated domain (SRA; Defossez and Stancheva, [@B39]). Among MBPs, MBDs were discovered first and remain the best studied to date. Both MBD1 and MeCP2 are highly expressed in the brain and play important roles in neurodevelopment and plasticity (Fan and Hutnick, [@B47]), while many other MBDs are involved in cancer (Parry and Clarke, [@B129]). We have shown that members of the MBD family play significant roles in the regulation of adult neurogenesis, which we discuss further below. Two members of the Kaiso family of zinc finger DNA-binding proteins are expressed primarily in the brain and can bind methylated CpG and induce gene silencing (Filion et al., [@B51]). Although the function of UHRFs is more mysterious, UHRF1 (also called Np95) is essential for the maintenance of DNA methylation: UHRF1 has a high affinity for hemi-methylated DNA and recruits DNMT1 to newly synthesized strands of DNA to establish DNA methylation (Sharif et al., [@B154]). A critical step in understanding the function of MBPs is to identify their binding specificity and targets. Despite keen interest and some progress (Jorgensen et al., [@B74]; Klose et al., [@B83]; Clouaire et al., [@B32]), much remains unknown, although advances in high-throughput sequencing should help move this effort forward.

Histone modifications
---------------------

The basic component of chromatin is the nucleosome: hundred and forty-seven base pairs of DNA wrapped twice around an octamer of histone proteins, which contains two copies of each histone, H2A, H2B, H3, and H4. The integration of variant histones into nucleosomes can alter the properties of chromatin and introduces an additional level of regulatory control. The amino acid side chains of the N-terminus histone tail extend from the nucleosome and can be post-translationally modified by acetylation, methylation, ubiquitination, phosphorylation, ribosylation, and SUMOylation; collectively, these are known as the "histone code" (Bernstein et al., [@B17]). Approximately half of the mass of chromatin consists of non-histone proteins that are responsible for writing and reading the code, a complex process that involves the cooperative and dynamic engagement of several species (Ruthenburg et al., [@B146]).

Chromatin is present in two general states: highly condensed heterochromatin associated with gene silencing, and loosely packed euchromatin associated with gene expression. Alone, histone modifications are unlikely to be sufficient for gene activation or repression: interactions with activators or repressors are also necessary for efficient implementation. The enzymes that add and remove histone modifications are not specific to certain nucleosomes; rather, they are recruited by specific DNA-binding proteins. Thus, it is the interactions between the histone code, nucleosome-binding proteins, and DNA-binding proteins that regulate chromatin structure and gene expression (Bernstein et al., [@B17]).

The acetylation of lysine residues is catalyzed by histone acetyltransferases (HATs), and the reversal of this modification is catalyzed by histone deacetylase (HDAC). Acetylation of histone 4 (H4Ac) directly loosens chromatin by neutralizing the positive charge of lysine, eliminating its attraction to the negatively charged DNA backbone of the neighboring nucleosome. Acetyl transferases also regulate gene expression *in trans* by recruiting other effector chromatin remodeling complexes (Ruthenburg et al., [@B146]). Mammals have 18 HDACs that are grouped into four classes, based on homology with yeast counterparts (de Ruijter et al., [@B38]). Class I HDACs (HDAC1, 2, 3, and 8) are localized in the nucleus. Although Class I HDACs are believed to be ubiquitously expressed, HDAC2 is upregulated in aNSCs differentiated into neuronal lineages, whereas HDAC1 is enriched in glia in the adult brain (MacDonald and Roskams, [@B105]). We have found that HDAC1 and 2, but not the other HDACs, are expressed in NSCs isolated from the adult DG (Zhao, unpublished observation). Class II HDACs (HDAC4, 5, 6, 7, 9, and 10) are able to shuttle in and out of the nucleus in response to certain cellular signals, and these HDACs display interesting cell type-specific expression. In fact, the upregulation of HDAC4, 5, 7, and 9 has been found in differentiating NSCs (Ajamian et al., [@B3]), and HDAC5 regulates NSC neuronal differentiation (Schneider et al., [@B150]). HDAC4 and 5 are enriched in the brain and are involved in neuronal maturation and neuroprotection (Majdzadeh et al., [@B106]). However, HDAC 3 and 5 are also reported to be highly expressed in proliferating NSCs and required for their proliferation (Sun et al., [@B172]). Therefore, cell type-specific HDACs may serve as important regulators in aNSCs and neuronal development, though their roles are not completely defined.

Histone methylation of lysine or arginine residues is catalyzed by a variety of methyltransferases (HMT) and can be associated with either gene silencing or activation, depending on the number of methyl groups (me1, 2, or 3) and their specific location on the histone. So far, 20 unique methylation marks have been uncovered: repressive marks include, but are not limited to, H3K9me3/me2, H4K20me3, H3K27me, and H4K59; activating marks include H3K4me3, H3K36me3, and H3K79me3 (Mosammaparast and Shi, [@B119]). The levels of repressive trimethylation of lysine 27 on histone 3 (H3K27me3) and activating trimethylation of lysine 4 (H3K4me3) are controlled by antagonistic groups of proteins called Polycomb (PcG) and Trithorax (TrxG). The addition of PcG-catalyzed H3K27me3 marks leads to the formation of heterochromatin and gene repression, whereas TrxG-catalyzed H3K4me3 marks result in euchromatin formation and gene expression. When both repressive and activating modifications occupy the same genomic region, the result is a bivalent chromatin state that is poised for either activation or further repression (Ringrose and Paro, [@B143]). Many HMTs are associated with cancer (reviewed in Albert and Helin, [@B4]) and neurodevelopmental diseases, including Sotos syndrome, Wolf--Hirschhorn syndrome, and 9q syndrome (Nimura et al., [@B123]).

In recent years, histone methylation was recognized as a dynamic modification that plays a role in gene regulation (Mosammaparast and Shi, [@B119]). This realization began with the discovery of lysine-specific demethylase 1 (LSD1), also known as lysine (K)-specific demethylase 1A (KDM1A), which is part of the REST complex (Shi et al., [@B156]). KDMs are known to regulate neuronal differentiation and fate specification, while mutations of KDMs have been tied to X-linked mental retardation (XLMR) and many cancers (Pedersen and Helin, [@B131]).

Non-coding RNAs
---------------

A large portion of the genome is transcribed into RNA but is never translated into protein. ncRNA is increasingly recognized as an important means of epigenetic regulation of cell fate determination and gene expression. The broad ncRNA category covers an array of small RNAs, including microRNAs (miRNAs), small nucleolar RNAs (snoRNAs), small interfering RNAs (siRNAs), and PIWI-interacting RNAs (piRNAs; Li and Zhao, [@B95]); of the small ncRNAs, this review will focus on miRNAs known to play a role in many facets of adult neurogenesis. miRNAs target mRNAs through base pairing between a short, 2- to 8-nucleotide seed sequence. Such a short complementation requirement means that a single miRNA may have dozens to hundreds of downstream targets (Bartel, [@B14]). The final processing steps of miRNA biosynthesis are mediated by Dicer and Drosha, members of the RNase III family, which cleave miRNA precursors into mature miRNA that is then loaded into silencing complexes (Krol et al., [@B86]). Although the mechanisms behind miRNA-mediated repression are not fully understood, the majority of miRNA-induced silencing effects result from the degradation of target mRNAs (Guo et al., [@B57]). Mechanistically, a miRNA binds to its target mRNA, frequently in the 3′ UTR, and recruits ribonucleoprotein complexes (miRNPs), also known as RNA-induced silencing complex (RISC), to deadenylate and degrade the mRNA. A number of miRNAs are known to play important roles in stem cells and development. For example, miR-124 is not only brain-enriched, but is also the most abundant miRNA in the embryonic and adult CNS. miR-124 levels increase during neuronal differentiation, and high levels of miR-124 promote neuronal differentiation; conversely, knockdown of endogenous miR-124 maintains proliferation and precursor status in several immature cell types, including adult NSCs. The downstream targets of miR-124 include splicing regulatory factor *Ptbp1*, pro-neuronal factors Ngn1 and NeuroD1, and REST (Makeyev et al., [@B107]; Visvanathan et al., [@B180]; Cheng et al., [@B28]; Yoo et al., [@B193]; Liu et al., [@B101]). The misregulation of miRNAs is involved in a number of neurodegenerative diseases, such as Alzheimer's and Parkinson's (Junn and Mouradian, [@B75]), and in many cancers (McDermott et al., [@B111]).

Another class of RNAs, long ncRNAs (lncRNAs), are gaining recognition as important mediators of cell fate specification, homeostasis, and plasticity in the CNS, though these roles have yet to be characterized fully (Wapinski and Chang, [@B183]). lncRNAs range in size from 200 bp to 10 kb, and though they do not code for protein, they undergo many of the same modifications as mRNA, including splicing and polyadenylation (Wang and Chang, [@B181]). Long intergenic ncRNAs (lincRNAs) are a type of lncRNAs found in gene introns; sometimes they are simply referred to as lncRNAs. There may be upward of 30,000 lncRNAs coded for in the human genome, and estimates are that over half of these are expressed in the CNS in a lineage-specific and developmentally regulated manner (Mercer et al., [@B113]). LncRNAs are involved in gene regulation at nearly every level, and the molecular mechanisms of their action can be characterized by four general archetypes: signal, decoy, guide, and scaffold (Wang and Chang, [@B181]). Many lncRNAs are involved in the regulation of chromatin structure; in fact, Khalil et al. ([@B78]) discovered that approximately 20% of lincRNAs are bound to Polycomb repressive complex 2 (PRC2), either alone or with other chromatin-associated complexes, such as Cofactor of REST (CoREST). The expression and biological functions of lncRNAs in the CNS, as well as their role in a number of neurodevelopmental and neurodegenerative diseases, are reviewed by Qureshi et al. ([@B136]). These RNAs likely alter gene expression through crosstalk with other epigenetic mechanisms, including modulation of chromatin modification enzymes and MBPs. The many roles that ncRNAs and other epigenetic pathways play in embryonic and adult neurogenesis have sparked significant interest in unraveling the complex networks that govern these crucial processes. In the next sections, we will discuss the functional crosstalk among these mechanisms.

Crosstalk among Epigenetic Mechanisms Regulates Neurogenesis
============================================================

Maintenance of multipotency, fate specification of NSCs, and phenotypic development of new neurons all require complex gene regulation. A host of experimental evidence has shown the critical roles of epigenetic regulation in this process (Li and Zhao, [@B95]; Liu and Zhao [@B100]). Not surprisingly, this complex regulation requires crosstalk among multiple epigenetic pathways. Here we present several examples of how interactions among epigenetic mechanisms control the neurogenic process.

Rest
----

Recent advances have shown that the element-1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) is part of an intricate and interconnected regulatory network of ncRNAs, chromatin remodeling complexes, and DNA-binding and -modifying complexes that ensures correct gene expression in the CNS during development and beyond (Qureshi et al., [@B135]). Highlighting its importance, REST has been implicated in a number of disorders, ranging from Down syndrome, XLMR, and epilepsy syndromes to neurodegenerative disorders, such as Huntington's disease, and cancers (Qureshi and Mehler, [@B137]). REST is a Krüppel-type zinc finger transcription factor that binds to 1/neuron-restrictive silencer element (RE1) sequences and other non-canonical genomic sites, where it acts as a scaffold for other multi-subunit complexes and DNA-binding proteins to activate, repress, or silence gene expression in a context-dependent manner (Qureshi et al., [@B135]). RE1 is found in many neural-specific genes, including ion channels, neurotransmitter receptors, and neurosensory factors, and is highly expressed in non-neuronal lineages, suggesting that REST acts as a repressor of neuronal genes in non-neuronal lineages (Qureshi et al., [@B135]). Since its initial discovery, REST has emerged as a central hub in a complex network of transcriptional and epigenetic mechanisms that precisely regulate neuronal development. REST recruits two main cofactors: mSin3 and CoREST. The N-terminus of REST recruits mSin3, which serves as a scaffold for HDAC1, 2, 4, and 5. The C-terminus of REST binds to CoREST and can recruit an astonishing array of proteins, including but not limited to HDAC1 and 2, MECP2, LSD1, G9a, Suc39h1, SCP1 (small C-terminal domain phosphatase), DNMTs, and other chromatin remodeling complexes (reviewed by Qureshi and Mehler, [@B137]). For example, MeCP2 targets the RE1 subset of neuronal genes and recruits HDACS, reflecting the possibility that both DNA methylation and histone remodeling are required to maintain these genes in a heterochromatin state. REST and CoREST are also found to complex with ATP-dependent chromatin remodeling mechanisms, such as BAF57, npBAF, and nBAF, in the suppression of neuronal gene function (Battaglioli et al., [@B15]). CoREST complexes can act independently of REST and may contribute to the dynamic regulation of different developmental stages (Ballas et al., [@B9]).

Deletion of REST is embryonic lethal (Chen et al., [@B26]), and the function of REST in stem cell lineage commitment is complex. In mouse ES cells, the transition from ESCs to NPCs is marked by a reduction in REST levels (Ballas et al., [@B9]); however, a knockdown of REST inhibits the formation of NSCs, NPCs, and neurons (Sun et al., [@B173]). Distinctly, the knockdown of CoREST impedes maintenance of NSCs and leads to altered neuronal differentiation (Abrajano et al., [@B1]). In adult neurogenic zones, the expression pattern of REST is biphasic; first, REST is expressed in quiescent, slowly dividing NSCs, then it diminishes in type 2b and type 3 transient amplifying cells, but reappears in immature and mature neurons (Gao et al., [@B53]). This study also shows that REST is required to maintain the adult NSC pool, as conditional knock down of REST in mice leads to a transient increase in neurogenesis that eventually depletes the NSC pool and leads to diminished neurogenesis (Gao et al., [@B53]). Further, beyond their roles in neurogenesis, REST and CoREST also modulate astrocyte and oligodendrocyte lineage specification and maintenance (Abrajano et al., [@B1]).

There is growing evidence to support close interactions between REST and small ncRNAs. A number of brain-enriched miRNAs, including miR-9, miR-124, and miR-132, as well as Dicer, are regulated by REST (Buckley et al., [@B22]). The relationship goes both ways: REST is itself a target of several of the miRNAs that it regulates. One of these, the bifunctional miR-9/miR-9\*, targets both REST and CoREST and forms a double-negative feedback loop (Packer et al., [@B128]). miR-9 is also regulated by the cAMP response element-binding (CREB); in non-differentiated cells, REST represses transcription of the miR-9 gene miR-9-2, then, at the same time REST is dislodged, CREB is phosphorylated and activates miR-9 expression during *in vitro* neuronal differentiation (Laneve et al., [@B87]). miR-124, on the other hand, reduces the expression of the REST cofactors CoREST, MeCP2, and SCP1 (Visvanathan et al., [@B180]). REST has also been implicated in the regulation of ESC pluripotency via miR-21, though its role remains controversial (Singh et al., [@B161]).

Long ncRNAs may also play an important role in the REST regulatory network. Computational analysis comparing annotated lncRNAs and RE1 motifs suggests that REST could regulate 23% of lncRNAs (Johnson and Buckley, [@B73]). This study identified two candidate lncRNAs with brain-specific expression patterns, AK046052 and AK090153, which are silenced by REST. Other ncRNAs may act through other REST cofactors; in fact, 13% of the lncRNAs expressed in HeLa cells bind to CoREST (Khalil et al., [@B78]). In another example, the lncRNA AIR accumulates at promoters, where it recruits G9a, a REST cofactor and histone methyltransferase involved in H3K9 di- and trimethylation, to silence gene expression (Nagano et al., [@B121]).

Regulation of PcG and TrxG proteins by DNA methylation or miRNAs
----------------------------------------------------------------

PcG and TrxG proteins are antagonistic, evolutionarily conserved members of a chromatin remodeling system that ensures proper expression of developmental programs and the maintenance of stem cell identities (Figure [1](#F1){ref-type="fig"}). During much of development, the target genes of PcG and TrxG complexes are marked by both activating H3K3me3 tags and repressing H2K27me3 tags. In this poised but repressed state, these genes can be quickly activated upon differentiation (Schuettengruber et al., [@B152]; Pietersen and van Lohuizen, [@B134]). In keeping with their role in maintaining stem cells, misregulation by PcG and TrxG proteins is frequently linked to the birth of cancer stem cells (Richly et al., [@B142]). PcG proteins are functional members of at least two multi-protein complexes that regulate chromatin structure: Polycomb repressive complexes 1 and 2 (PRC1 and PRC2; Li and Zhao, [@B95]; Pietersen and van Lohuizen, [@B134]). Each complex contains a distinct set of core proteins that were first identified and named in flies. In mammals, PRC2 is composed of four core components: enhancer of zeste 1 or 2 (EZH1 or EZH2), embryonic ectoderm development (EED), suppressor of zeste 12 (SUZ12), and RbAp46/48 (reviewed in Margueron and Reinberg, [@B110]). The PRC1 components are Chromobox (CBX) 2/4/6/7/8, PH1/2/3, RING1A/1B, and Bmi-1/Mel13/NSPC1 (Vidal, [@B177]). How the complexes are recruited to specific chromatin targets is not fully understood, but recent evidence indicates recruitment relies on not only DNA-binding proteins but ncRNAs (Khalil et al., [@B78]; Wang and Chang, [@B181]). In a simple model, PRC2 is recruited to target genes and catalyzes the trimethylation of H3K27, and PRC1 recognizes the H3K27me3 mark of PRC2 and mediates ubiquitination of H2AK119 to maintain gene repression; however, this step-wise model of recruitment is not always accurate, as the complexes can act independently of each other (Margueron and Reinberg, [@B110]). Interactions among PcG protein components and between PcG members and other regulatory proteins, including HATs, HDACs, REST, and TrxG proteins, are essential for PcG functions (Cao et al., [@B24]; Buchwald et al., [@B21]; Vidal, [@B177]).

![**Crosstalk between epigenetic pathways and Polycomb group (PcG) and Trithorax group (TrxG) proteins during adult neurogenesis**. The figure illustrates a possible model of crosstalk between epigenetic pathways and PcG and TrxG protein complexes during adult neurogenesis. In the bivalent chromatin state, genes are poised for either rapid induction or further repression; activating H3K4me3 marks and repressing H2K27me3 marks are both present, as are the antagonistic TrxG and PcG complexes (left panel). TrxG and other activating complexes displace PRC2 and loosen the chromatin which enables the expression of neuronal genes (top right panel). Conversely, the recruitment of PRC1 and other repressive complexes (possibly REST) condenses chromatin and suppresses cell-cycle inhibitors and neuronal genes, leading to neural stem cell (NSC) self-renewal (bottom right).The addition of activating H3K4me3 marks and the removal of repressive H2K27me3 marks is associated with chromatin loosening while further H2K27 trimethylation and the addition of repressive H2AUb marks condenses chromatin. Members of PcG and TrxG proteins that have been shown to regulate neurogenesis are shown in black (see text for references). Crosstalk among microRNAs, long non-coding RNAs and PcG and TrxG proteins are shown in black (adult neurogenesis), purple (development; Brett et al., [@B20]; Song et al., [@B168]), red for ESC differentiation (O'Loghlen et al., [@B126]), and blue (cancer; Lau et al., [@B88]; Wong and Tellam, [@B189]; Friedman et al., [@B52]; Shimono et al., [@B158]; Wellner et al., [@B186]; Iliopoulos et al., [@B69]; Cao et al., [@B23]).](fnins-06-00059-g001){#F1}

Evidence for the importance of PRC1 in neurogenesis comes from the neurodevelopmental phenotypes of mice lacking functional B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1; Lobo et al., [@B102]). Mounting data point to an important role for Bmi-1 in controlling self-renewal and senescence of different types of stem cells, among them cancer stem cells and NSCs (Shi et al., [@B157]; Schuringa and Vellenga, [@B153]). Bmi-1 deficiency leads to reduced proliferation and self-renewal of SVZ neural progenitors, and these effects are mediated in part through the transcriptional repression of three cell-cycle inhibitors: p16^Ink4a^, p19^Arf^, and p21 (Molofsky et al., [@B118]; Fasano et al., [@B49], [@B50]). Conversely, overexpression of Bmi-1 increases the self-renewal of SVZ-derived cells *in vitro* and increases proliferation *in vivo* (Yadirgi et al., [@B191]). However, one study found that transgenic Bmi-1 overexpression did not have significant effect on aNSC proliferation in either the SVZ or the DG (He et al., [@B64]); therefore demanding further analysis in future studies. The core component of PRC2, EZH2, is essential for stem cell maintenance and fate specification in many cell lineages, including neurons (reviewed in Yu et al., [@B194]). The role of EZH2 has not been explored directly in adult neurogenesis, but several lines of evidence indicate it might mirror the effects of Bmi-1 in postnatal neuronal development. In embryonic NSCs, Ezh2 is highly expressed in proliferating cells and its expression declines as cells differentiate into neurons (Sher et al., [@B155]). In embryonic epidural progenitors, the loss of Ezh2 does not change the fate of these cells; rather, it reduces their proliferation through the upregulation of p16^Ink4a^ and p19^Arf^ (Ezhkova et al., [@B46]). Moreover, in human embryonic fibroblast cells, the ability of Bmi-1 to repress p16 and p19 was dependent on EZH2 (Bracken et al., [@B19]). In cortical progenitor cells, the loss of EZH2 led to increased production of neurons at the expense of the progenitor population and improper developmental timing (Pereira et al., [@B132]). Other PcG members of PRC2 are also necessary to maintain neural progenitor cells. For example, ESCs from SUZ12−/− mice were unable to form neurons under normally permissive neuronal differentiation conditions *in vitro* (Pasini et al., [@B130]). Furthermore, knocking down EED enhanced neuronal differentiation in embryonic NSCs (Hirabayashi et al., [@B66]).

The question becomes how PcG proteins themselves are regulated. Evidence suggests that other epigenetic pathways contribute significantly to the regulation of PcG proteins in the context of neurogenesis. For example, Bmi-1 is targeted by several miRNAs, including miR-128 in glioblastoma cells (Cui et al., [@B36]; Dong et al., [@B42]), meaning such regulation might also exist in NSCs. Ezh2 is also regulated by miRNAs. In adult NSCs derived from the mouse forebrain, overexpression of miR-137 increases proliferation, whereas reduction of miR-137 enhances the neuronal differentiation of these cells (Szulwach et al., [@B174]). This modulation is believed to occur through miR-137's post-transcriptional repression Ezh2, which leads to a global reduction in the repression of H3K27me3 marks. Moreover, miR-137 is regulated by MeCP2 (which will be discussed later), a fact that highlights the extensive crosstalk between epigenetic pathways (Szulwach et al., [@B174]). Recently, microdeletions of miR-137 were associated with intellectual disability (Willemsen et al., [@B187]), underscoring the significance of its interaction with Ezh2 and MeCP2.

LncRNAs may also be involved in the regulation of PcG. As discussed previously, components of PRC1 and PRC2, Bmi-1 and EZH2, respectively, are required to correctly regulate the switch between proliferation and differentiation through the expression of two cell-cycle inhibitors/tumor suppressors, p16^Ink4a^ and p19^Arf^. The expression of the Ink4a/ARF/Ink4b locus, which codes for p16 and p19, as well as p15 and p14, is regulated by the lncRNA ANRIL (antisense ncRNA in the INK4 locus) via direct interaction with subunits of PRC1 and PRC2. ANRIL is a 3.8-kb ncRNA that is expressed in the opposite direction of and overlaps with the Ink4a locus. CBX7, an H3k27me3-recognizing component of PRC1, can bind directly to both ANRIL and H3K27me3, and both interactions are required for CBX7 to repress the INK4A and INK4B loci (Yap et al., [@B192]). ANRIL is also involved in the recruitment of PRC2, through SUZ12, to p15^INK4B^ in the INK4A/ARF/INK4B region, and is necessary for its repression (Kotake et al., [@B84]). In this regulatory scheme, ANRIL acts as a scaffold that recruits PRC1, PRC2, and possibly other factors to regulate gene expression (Wang et al., [@B182]). LncRNAs are emerging as significant regulators of development and fate specification. Considering the intersection of regional and cell-specific epigenetic pathways and the diversity of chromatin remodeling complexes, the capacity for fine-tuned regulation of gene expression is extraordinary. HOTAIR is a 2.2-kb lincRNA encoded in the HOXC locus that represses transcription of HOXD genes *in trans* by recruiting PRC2 (Rinn et al., [@B144]). Specific phosphorylation of EZH2 is found to increase its affinity to HOTAIR, resulting in increased recruitment of PRC2 to Hox genes (Kaneko et al., [@B76]). Through its 3′ end, HOTAIR also recruits CoREST along with the lysine-specific histone methyltransferase, LSD1, which recognizes activating H3K4me3 marks (Tsai et al., [@B175]). Thus, lncRNA can recruit different chromatin remodeling complexes and resolve bivalent chromatin states via H3K4 demethylation and H3K27 methylation. Recently, the HOTAIRM1 was shown to be elevated in early differentiating neurons generated from human iPS (induced pluripotent stem) cells, as was JARID, a regulator of Polycomb repressive complexes (Lin et al., [@B97]). Both HOTAIR and ANRIL have been implicated in a number of cancers (Wapinski and Chang, [@B183]), but whether these ncRNAs play a role in adult neurogenesis remains to be seen.

The composition of TrxG complexes is heterogeneous; most contain MLL1--3, a SET domain factor, and its associated proteins, such as WDR5 and ASH2L, whereas others contain NURF complexes or ATP-dependent SWI/SNF complexes (Schuettengruber et al., [@B152]). Mixed-lineage leukemia 1 (Mll-1) is a TrxG member that contains a SET domain with H3K4 methyltransferase activity. MLL family members also interact with UTX, a di- and tri-methyl-H3K27 transferase that is part of the Jumonji-C family of proteins (Lee et al., [@B90]). Thus, Mll1 complexes may have the ability to identify genes for transcription and remove repressive marks, resolving bivalent chromatin situations. In 2009, Lim et al. revealed that Mll1 is specifically required for neuronal differentiation in the adult SVZ, but not for glial or oligodendrocyte differentiation; in the absence of Mll1, the level of the neuron-specific transcription factor dlx2 was reduced, but the levels of MASH1 or olig2, factors necessary for glial and oligodendrocyte generation, were not. Surprisingly, they found that while all three genes possessed activating H3K4me3 marks, only *dlx2* were held in the bivalent chromatin state with repressing H3K27me3 marks (Lim et al., [@B96]). Thus, epigenetic control of the bivalent chromatin state is essential for proper adult neurogenesis. TrxG proteins are also regulated by miRNAs. For example, miR-17-92 cluster miRNAs are known regulators of MLL, and dysregulation of these clusters of miRNAs contributes to cellular transformation (Mi et al., [@B114]; Wong et al., [@B190]). Since multiple components of repressing PcG complexes are subject to regulation by ncRNAs, it is not surprising that lncRNAs are involved in the antagonistic, activating TrxG complexes. For example, the long intergenic RNA (lincRNA) HOXA transcript at the distal tip (HOTTIP) is found to be necessary for maintaining MLL complexes on HoxA genes (Wang et al., [@B182]).

MBD1 and MeCP2 control the expression of other epigenetic factors
-----------------------------------------------------------------

Both MBD1 and MeCP2 are highly expressed in the brain and play important roles in neurodevelopment and plasticity (Fan and Hutnick, [@B47]). As discussed below, we and others have found that both MBD1 and MeCP2 regulate NSCs and neurogenesis through transcriptional regulation of other epigenetic factors (summarized in Figure [2](#F2){ref-type="fig"}). Mutations in MeCP2 are the cause of the neurodevelopmental disorder Rett syndrome (RTT), but they are also associated with a number of other neurological disorders, including cases of Angelman syndrome, Prader--Willi syndrome, autism, and non-syndromic mental retardation (Chahrour and Zoghbi, [@B25]). Mouse models have replicated key phenotypes of RTT and revealed that MeCP2 plays a critical role in neuronal maturation and synaptogenesis, in part through the regulation of dendritic morphology, synaptic transmission, and long-term plasticity (Zhao et al., [@B196]; Smrt et al., [@B164]). Both clinically and in mouse models of Rett syndrome, loss of MeCP2 and increased dosage both result in similar pathology, highlighting the necessity for its precise control (Chahrour and Zoghbi, [@B25]). In adult NSCs from the DG, MeCP2 is not critical for early neurogenesis; rather, MeCP2 is important during the transition from immature to mature neurons (Smrt et al., [@B163]). Indeed, MeCP2 is highly expressed in post-mitotic neurons in many regions of the brain, and its loss results in global alterations in chromatin structure, including increased histone acetylation and increased H1 nucleosome occupancy (Skene et al., [@B162]). MeCP2 expression in astrocytes has recently been shown to have significant impact on neuronal function and RTT pathology (Ballas et al., [@B10]; Lioy et al., [@B98]). Since astrocyte-"specific" manipulations utilize the promoter of GFAP, a protein that is also expressed in NSCs, it is possible that some of these effects might be, at least in part, due to changes in NSCs.

![**Methyl-CpG binding proteins MeCP2 and MBD1 regulate multiple stages of adult neurogenesis**. The figure demonstrates the neurogenic process in the adult hippocampus, although some of the mechanisms were obtained by studying SVZ neurogenesis. MicroRNAs, molecular mediators, and other inputs that are known to regulate the neurogenesis process are summarized. MBD1 represses the self-renewal and promotes differentiation of NSCs through either direct regulation of critical stem cell genes (e.g., Fgf-2) or indirect crosstalk with miRNA pathways (e.g., miR-184). MeCP2 plays important roles at multiple stages of neurogenesis from NSC fate specification to maturation and integration of new neurons. Similar to MBD1, MeCP2 is known to both directly regulate the expression of developmental genes (e.g., BDNF) and indirectly modulate gene expression through miRNA pathways (e.g., miR-137 and miR-132). On the other hand, MeCP2 is regulated by neuronal activity and at least in part through CREB-regulated miRNA (see text for references).](fnins-06-00059-g002){#F2}

MeCP2 may translate signaling cascades into epigenetic gene regulation. In neurons, neuronal activity leads to phosphorylation of MeCP2 at specific sites, which differentially affects its binding to gene promoters, such as brain-derived neurotrophic factor (BDNF), a neurotrophic factor critical for neuronal development and synaptic plasticity (Na and Monteggia, [@B120]). BDNF signaling via its receptor, TrkB, is essential for neurogenesis in hippocampal NSCs (Li et al., [@B94]). miRNAs are emerging as important regulators at many points in the MeCP2 regulatory pathway. *MeCP2* mRNA transcript is targeted by miRNA-132, a neuronal activity and CREB-regulated miRNA that regulates neuronal maturation and dendritic morphology in neonate rat hippocampal neurons (Klein et al., [@B81]; Wayman et al., [@B184]). The transgenic overexpression of miR-132 decreased MeCP2 levels and increased dendritic spine density in isolated primary hippocampal neurons (Hansen et al., [@B63]). Undoubtedly, neuronal maturation is regulated by an extensive, intertwined network of epigenetic pathways.

In addition to being a target of miRNAs, MeCP2 is also involved in miRNA regulation. miR-137 is enriched in the brain and miR-137 levels increase upon neuronal differentiation of adult forebrain-derived NSCs (Silber et al., [@B160]; Smrt et al., [@B166]). miR-137 was found to modulate the proliferation and differentiation of forebrain aNSCs; the translation of miR-137 is repressed by MeCP2 and Sox2, a transcription factor that regulates stem cell self-renewal (Szulwach et al., [@B174]). One target of miR-137 in NSCs is the PRC2 component EZH2 (Szulwach et al., [@B174]). Interestingly, EZH2 has been shown to recruit DNMT to promoters of genes destined for DNA methylation and gene repression (Viré et al., [@B179]). Therefore, the crosstalk among these epigenetic mechanisms may coordinately regulate NSC fate. miR-137 also regulates later stages of neurogenesis: in immature neurons, overexpression of miR-137 inhibited hippocampal DG neuronal maturation by targeting Mind Bomb-1, a RING ubiquitin ligase (Smrt et al., [@B165]). Significantly, in embryonic NSCs, miR-137 seems to play a role in the transition from proliferation to differentiation, as miR-137 positively regulates neuronal differentiation of embryonic NSCs by targeting LSD1, a component of a transcriptional complex containing HDACs and nuclear receptor TLX, an essential regulator in stem cell self-renewal (Sun et al., [@B171]).

Methyl binding domain proteins are essential in linking DNA methylation to the regulation of gene expression. In humans, mutations in MBD1 have been linked to a subset of individuals with autism (Li et al., [@B92]; Cukier et al., [@B37]), as well as to some cancers (Sansom et al., [@B148]). MBD1 null mice exhibit decreased neurogenesis in the DG, impaired spatial learning, and reduced long-term potentiation in the hippocampus (Zhao et al., [@B197]). These mice also show signs of depression, believed to be a result of decreased adult neurogenesis (Allan et al., [@B5]). MBD1 binds directly to the promoter of Fgf-2 (fibroblast growth factor 2), a molecule that promotes proliferation and is commonly used to expand NSC populations, to regulate its expression. Furthermore, a DNA methylation inhibitor blocked the effects of MBD1 in forebrain-derived aNSCs and increased Fgf-2 expression, underscoring the important role the methylation state of the promoter plays (Li et al., [@B93]). In part, MBD1 regulates neurogenesis by silencing miR-184; an increased level of miR-184 promotes proliferation and hinders the differentiation of hippocampal GD adult NSCs *in vivo* and forebrain-derived NSCs *in vitro*. In turn, miR-184 binds the 3′ UTR of Numb like (Numbl), a signaling protein required for differentiation in adult neurogenesis, and targets it for degradation (Liu et al., [@B99]). Numbl is known to inhibit the Notch pathway (Petersen et al., [@B133]), which has a significant impact on neurogenesis. Interestingly, Notch signaling was recently shown to be required for FGF-2 receptor-dependent growth in embryonic cortical cells (Rash et al., [@B139]), bringing together a possible regulatory loop involving MBD1, FGF-2, miR-184, Notch, and Numbl. It is conceivable that regulation of miRNA expression by MBDs requires cooperation from other epigenetic machinery. In fact, HDAC1, 2, and 3 can facilitate the regulation of gene expression by MBD1 in cancer cells (Ng et al., [@B122]; Villa et al., [@B178]). Inhibition of both DNA methylation and HDAC is used for cancer treatment (Griffiths and Gore, [@B56]). Moreover, miRNA and HDAC-mediated pathways can cooperate to reprogram somatic cells to pluripotency (Anokye-Danso et al., [@B6]). It will be interesting to see whether coordinated manipulation of all three epigenetic pathways will be more effective at controlling cell fate.

Environmental Governance of Epigenetic Crosstalk
================================================

It is well known that environmental stimuli can modulate neurogenesis, both during early development and in adulthood (Li and Zhao, [@B95]; Barkho and Zhao, [@B13]). Numerous factors are found to promote adult neurogenesis, including exercise and environmental stimulation. Furthermore, depression, brain injury, and stress have all been linked to reduced adult neurogenesis. The relative impact of nature versus nurture on human neurodevelopment and brain function has been a topic of hot discussion and an active research area. The significant overlap among epigenetic pathways could explain how environmental factors regulate neurogenesis and NSC fates with a high degree of complexity. Here we give some examples as possible mechanisms whereby environmental stimulation can be translated into changes in gene expression.

Neuronal activities lead to epigenetic changes
----------------------------------------------

A number of studies show that long-term potentiation and memory formation require histone acetylation, particularly at H3 and H4, and that extrinsic stimuli inhibiting histone acetylation, such as treatment with HDAC inhibitors and alcohol exposure, inhibit learning and memory (Crepaldi and Riccio, [@B35]). Interestingly, these treatments also impact NSCs and neurogenesis, with potential downstream effectors of these treatments including neurotrophins.

Neurotrophins, such as BDNF, seem to play a crucial role in the environmental influence on neurogenesis. BDNF is known to govern maturation, including the dendritic branching and synaptic development of new neurons (Smrt and Zhao, [@B167]). At a neurogenic level, BDNF promotes neuronal fate choice and terminal differentiation of NSCs both *in vitro* and in adult DG and SVZ (Li et al., [@B94]). An enriched environment, physical exercise, and neuronal activity are all found to increase levels of BDNF (Smrt and Zhao, [@B167]). It is not surprising that BDNF, as a key point of regulation for neurogenesis, is itself regulated by multiple mechanisms, including epigenetic pathways. MeCP2 is known to work with REST/NRSF to recruit HDACS and suppress transcription of the BDNF promoter, and neuronal depolarization results in the release of MeCP2 from the BDNF promoter, thereby allowing for its transcription (Ballas et al., [@B9]; Zhou et al., [@B199]). In addition, miR-132 levels increase in response to both BDNF and neuronal activity in the hippocampus, olfactory bulb, and striatum, indicating that miR-132 may act in a feedback loop that increases neural plasticity (Nudelman et al., [@B124]; Remenyi et al., [@B141]). Such crosstalk may explain how depolarization is translated into neuronal termination differentiation and maturation, and why there is a reduced BDNF level in MeCP2-deficient mice.

It has long been known that electroconvulsive therapy, a treatment for depression, can promote hippocampal neurogenesis, which might be a causal link to better cognitive function; however, the mechanism underlying this is unclear (Ming and Song, [@B115]). One study shows that ECT leads to greater expression of the immediate early gene Gadd45b in hippocampal neurons, which catalyzes DNA demethylation of several important genes involved in adult neurogenesis, such as *Bdnf*, *Fgf-1*, and NR2 subunit of the NMDA receptor (Ma et al., [@B104]). In adult brains, neuronal activity-dependent DNA demethylation involves the activity of Tet1 through the 5hmC pathway (Guo et al., [@B58]).

Neural inflammation, stress, and disease lead to changes in epigenetic states
-----------------------------------------------------------------------------

Many negative factors can impact neurogenesis, but the mechanism remains unclear for most of these influences; epigenetic changes seen in some of these conditions may explain the missing link.

Drug and alcohol abuse is known to reduce NSC self-renewal, neuronal differentiation, neuronal maturation, and neurogenesis (Cho and Kim, [@B29]). The CREB protein and its cofactor, CREB-binding protein (CBP), are known to regulate NSCs, as well as neurogenesis and memory, and such function is dependent on the HAT function of CBP (Lee et al., [@B91]; Lopez-Atalaya et al., [@B103]). We and others have found that fetal alcohol exposure leads to a significant reduction in CBP expression, to levels similar to those seen in human Rubinstein--Taybi syndrome (heterozygotic loss of CBP gene; Constantinescu et al., [@B33]; Guo et al., [@B60]). Alcohol exposure also leads to changes in DNA methylation in the promoter of key genes involved in development and NSCs (Zhou et al., [@B198]). Crosstalk among epigenetic pathways is a likely mechanism behind drug and alcohol abuse-induced cognitive deficits (Mandrekar, [@B109]).

Stroke is also found to cause DNA methylation changes, and altered DNA methylation may be a biomarker for cardiovascular disease and stroke. Inhibition of DNMTs and HDACs could be used as a potential treatment for reducing the neuronal death and tissue damage that result from stroke (for a recent review, see Kim et al., [@B79]; Baccarelli et al., [@B8]; Qureshi and Mehler, [@B138]). Stroke is known to result in enhanced neurogenesis in the SVZ and such enhanced endogenous neurogenesis has been considered as a potential endogenous cell therapy for over a decade. However, the mechanism behind this neurogenic response is unclear (Barkho and Zhao, [@B13]). Recently, focal cerebral ischemia in a rodent stroke model was found to result in reduced expression of miR-124, which targets Jagged-1 (JAG1), a ligand of Notch (Liu et al., [@B101]). The activation of the JAG-Notch signaling pathway leads to enhanced SVZ NSC proliferation and might prove to be at least one of the key mechanisms behind stroke-induced neurogenesis. Treatment with sodium butyrate, a HDAC inhibitor, stimulates SVZ and DG neurogenesis in the ischemic brain, possibly by promoting the expression of CREB and BDNF (Kim et al., [@B79]).

Aberrant DG neurogenesis as a signature of temporal lobe epilepsy has been appreciated for over a decade; however, whether abnormal neurons are the cause or consequence of seizure is still unclear (Schneider-Mizell et al., [@B151]). Alterations in histone modifications, DNA methylation, and ncRNA profiles have been seen in epileptic brains and animal models, therefore epigenetic mechanisms are proposed to be part of the etiology, as well as a possible treatment for, epilepsy (for a recent review, see Urdinguio et al., [@B176]). Valproic acid (VPA), a HDAC inhibitor and an antiepileptic drug, blocks seizure-induced neurogenesis and protects animals from seizure-induced deficits in a hippocampus-dependent learning task (Jessberger et al., [@B72]), although the specific targets of HDAC inhibitor treatment remain unclear. Quite a few miRNAs exhibit altered expression profiles in epileptic tissues (Aronica et al., [@B7]; Nudelman et al., [@B124]; Hu et al., [@B68]; Risbud et al., [@B145]; Song et al., [@B169]), and some of them, such as miR-21, let-7e, miR-125, and miR-132, are known to regulate neurogenesis (Liu and Zhao, [@B100]). Future studies are needed to determine whether the expressions of these miRNAs are likely controlled by histone modification and DNA methylation, as well as whether these miRNAs can also be used as therapeutic targets, along with HDAC inhibitors, for the treatment of epilepsy.

The link between depression, neurogenesis, and epigenetic changes has been discussed extensively for years (Hsieh and Eisch, [@B67]). HDAC inhibitors are widely considered a treatment for depression (Grayson et al., [@B55]), and DNA methylation inhibitors, such as 5-aza cytidine, can also lead to dose-dependent increases in BDNF expression and anti-depression effects (Sales et al., [@B147]). Not surprisingly, changes in miRNA expression are seen in cases of human depression and in animal models, making the role of non-coding miRNAs in major depression apparent (for recent reviews, see Dwivedi, [@B44]; Ha, [@B62]; O'Connor et al., [@B125]). However, as is the case with epilepsy, how depression affects miRNA expression is still unclear. Epigenetic crosstalk in the etiology of depression is likely to become a fruitful area of future study. Of relevance here, the regulation of the stress pathway is also known be to under epigenetic control. Maternal care during the early postnatal period modulates the DNA methylation status of glucocorticoid receptors and glutamic acid decarboxylase 1 (GAD1) promoter (Zhang et al., [@B195]), and treatment with both HDAC inhibitor and DNA methylation inhibitor can alter the maternal effects (Weaver, [@B185]).

Conclusion
==========

Neurogenesis is a complex process requiring coordinated control at multiple levels in a time- and stage-dependent manner, and the sensitivity of neurogenesis to environmental factors is what allows us to make necessary adjustments to fit better into our environment. Epigenetic mechanisms, with their flexibility and versatility, are uniquely suited to fulfill such a requirement. Although a large body of literature presents data on the epigenetic regulation of NSCs and neurogenesis, and its subsequent impact on cognitive functions, particularly learning and memory, few studies have dealt with the crosstalk among these individual mechanisms. At a conceptual level, crosstalk among these mechanisms is inevitable. As a flood of publications offer evidence of miRNA regulation of neurogenesis and related diseases, it is the downstream targets of these miRNAs that have been heavily focused on. The control of these miRNAs, particularly by DNA methylation and chromatin remodeling, as well as processes altered by these diseases, have not been given full attention. Future studies, with the goal of dissecting this crosstalk, both at the individual pathway level and global network level, will help us understand how neurogenesis is regulated and how the environment impacts these processes. Breakthroughs from such studies will likely yield new therapeutic targets for research to pursue.
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